UnitedHealth Group Inc (UNH) : Murphy Pohlad Asset Management reduced its stake in UnitedHealth Group Inc by 1.49% during the most recent quarter end. The investment management company now holds a total of 13,509 shares of UnitedHealth Group Inc which is valued at $1,812,773 after selling 205 shares in UnitedHealth Group Inc , the firm said in a disclosure report filed with the SEC on Oct 13, 2016.UnitedHealth Group Inc makes up approximately 1.38% of Murphy Pohlad Asset Management’s portfolio.
Other Hedge Funds, Including , Premier Asset Managment reduced its stake in UNH by selling 1,050 shares or 1.72% in the most recent quarter. The Hedge Fund company now holds 59,970 shares of UNH which is valued at $8,047,374. UnitedHealth Group Inc makes up approx 2.05% of Premier Asset Managment’s portfolio. Maple Securities Usa Inc sold out all of its stake in UNH during the most recent quarter. The investment firm sold 36,890 shares of UNH which is valued $5,093,771.Vontobel Asset Management Inc reduced its stake in UNH by selling 74,855 shares or 3.85% in the most recent quarter. The Hedge Fund company now holds 1,867,387 shares of UNH which is valued at $257,848,797. UnitedHealth Group Inc makes up approx 2.05% of Vontobel Asset Management Inc’s portfolio.Fisher Asset Management boosted its stake in UNH in the latest quarter, The investment management firm added 796 additional shares and now holds a total of 3,782 shares of UnitedHealth Group Inc which is valued at $522,219.Harbour Capital Advisors reduced its stake in UNH by selling 200 shares or 1.63% in the most recent quarter. The Hedge Fund company now holds 12,038 shares of UNH which is valued at $1,656,429. UnitedHealth Group Inc makes up approx 0.89% of Harbour Capital Advisors’s portfolio.
UnitedHealth Group Inc closed down -3.33 points or -2.41% at $134.75 with 33,53,588 shares getting traded on Tuesday. Post opening the session at $137.32, the shares hit an intraday low of $134.37 and an intraday high of $137.69 and the price fluctuated in this range throughout the day.Shares ended Tuesday session in Red.
On the company’s financial health, UnitedHealth Group Inc reported $1.96 EPS for the quarter, beating the analyst consensus estimate by $ 0.07 according to the earnings call on Jul 19, 2016. Analyst had a consensus of $1.89. The company had revenue of $46485.00 million for the quarter, compared to analysts expectations of $45039.08 million. The company’s revenue was up 28.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.64 EPS.
Many Wall Street Analysts have commented on UnitedHealth Group Inc. UnitedHealth Group Inc was Upgraded by Argus to ” Buy” on Jul 22, 2016. Company shares were Reiterated by RBC Capital Mkts on Jul 20, 2016 to “Outperform”, Firm has raised the Price Target to $ 165 from a previous price target of $157 .Company shares were Reiterated by Mizuho on Jul 19, 2016 to “Buy”, Firm has raised the Price Target to $ 160 from a previous price target of $156 .
UnitedHealth Group Incorporated is a health and well-being company. The Company’s business platforms include UnitedHealthcare and Optum. UnitedHealthcare provides health care benefits to various customers and markets. Optum is a health services business serving the health care marketplace including payers care providers employers Governments life sciences companies and consumers. The Company’s business platforms have four segments: UnitedHealthcare OptumHealth OptumInsight and OptumRx. UnitedHealthcare includes UnitedHealthcare Employer & Individual UnitedHealthcare Medicare & Retirement UnitedHealthcare Community & State and UnitedHealthcare Global. OptumHealth is a health and wellness business serving the physical emotional and financial needs of individuals. OptumInsight provides technology operational and consulting services to participants in the health care industry. OptumRx provides a range of pharmacy benefit management (PBM) services.